Alcon Inc. (ALC)

79.57 -1.19 (-1.47%) At close: 04:00PM EDT

Alcon Inc.

Chemin de Blandonnet 8
Vernier
Geneva 1214
Switzerland
41 589 112 110
https://www.alcon.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 25,315

Key executives

Name	Title	Pay	Exercised	Year born
Mr. F. Michael Ball	Executive Chairman	1.17M	N/A	1955
Mr. Arthur B. Cummings M.D.	Executive Director	284.68k	N/A	1962
Mr. David J. Endicott	CEO & Director	4.82M	N/A	1965
Mr. Timothy C. Stonesifer	Chief Financial Officer	N/A	N/A	1967
Margaret Buckley	Chief Accounting Officer	N/A	N/A	N/A
Dr. Franck Leveiller	Senior VP, Head of Global R&D and Chief Scientific Officer	N/A	N/A	N/A
Ms. Sue-Jean Lin	Senior VP and Chief Information & Transformation Officer	N/A	N/A	1959
Mr. Royce R. Bedward	Senior VP, General Counsel & Corporate Secretary	N/A	N/A	1966
Ms. Kimberly Martin	Senior VP, Chief HR Officer & Corporate Communications	N/A	N/A	1975
Mr. Laurent Attias	Head of Corporate Development, Strategy, BD&L and M&A	N/A	N/A	1968

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Corporate governance

Alcon Inc.’s ISS governance QualityScore as of 1 April 2024 is 2. The pillar scores are Audit: 5; Board: 3; Shareholder rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.